BioXcel Therapeutics, Inc. (BTAIQ): Depreciation & Amortization

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Depreciation & Amortization is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$297.0K
Year ended 2021-12-31
+159.5%
3-year compound annual growth
2017-12-31: $1.0K2018-12-31: $17.0K2019-12-31: $156.0K2020-12-31: $188.0K2021-12-31: $297.0K$297.0K
2017-12-31 Depreciation & Amortization (USD) 2021-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2021-12-31$297.0K+58.0%2022-03-11, From 2021-01-01
2020-12-31$188.0K+20.5%2022-03-11, From 2020-01-01
2019-12-31$156.0K+817.6%2021-03-12, From 2019-01-01
2018-12-31$17.0Kn/m2020-03-09, From 2018-01-01
2017-12-31$1.0Kn/a2019-03-12, From 2017-01-01